Search Within

Yingbei Chen

  1. "Body Imaging Service"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (9)
Groups
  1. Body Imaging Service (20)
  2. Department of Pathology and Laboratory Medicine (20)
  3. Radiology, Department of (20)
  4. Department of Medicine (18)
  5. Genitourinary Oncology Service (18)
  6. Solid Tumor Oncology Division (18)

More Groups

People
  1. Martin Voss (17)
  2. Robert Motzer (17)
  3. Darren Feldman (15)
  4. Chung-Han Lee (13)
  5. Maria Carlo (11)
  6. Devyn Coskey (9)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Cancer Research (3)
  3. European Urology (2)
  4. BJU International (1)
  5. Cancer (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (4)
  3. Elsevier Inc. (2)
  4. Elsevier Science, Inc. (2)
  5. Wiley Blackwell (2)
  6. Elsevier B.V. (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib plus nivolumab in patients with non–clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Journal Article

    Fitzgerald, K. N.; Lee, C. H.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y.; Lefkowitz, R. A.; Shah, N. J.; Owens, C. N.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma
    Meeting Abstract

    Vuong, L.; Kuo, F.; Jiang, H.; Mascareno, E. A.; Rappold, P.; Sabio, E.; Weiss, K.; Cornish, A.; Reese, S.; Adlesic, M.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy
    Journal Article

    Carlo, M. I.; Attalla, K.; Mazaheri, Y.; Gupta, S.; Yildirim, O.; Murray, S. J.; Coskey, D. T.; Kotecha, R.; Lee, C. H.; Feldman, D. R.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Isolated urethral metastasis from appendiceal mucinous adenocarcinoma
    Journal Article

    Causa Andrieu, P. I.; Golia Pernicka, J. S.; Faria e Silva Costa, G.; Chesnut, G. T.; Shandu, J. S.; Ying-Bei, C.; Petkovska, I.
    Clinical Imaging (2020)

    Fulltext@MSK | Save
  • Hyperpolarized MRI visualizes Warburg effects and predicts treatment response to mTOR inhibitors in patient-derived ccRCC xenograft models
    Journal Article

    Dong, Y.; Eskandari, R.; Ray, C.; Granlund, K. L.; Dos Santos-Cunha, L.; Miloushev, V. Z.; Tee, S. S.; Jeong, S.; Aras, O.; Chen, Y. B.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save